2,002 results on '"Laufs, Ulrich"'
Search Results
2. GLP-1-Rezeptor-Agonisten bei Patienten mit Herzinsuffizienz?: STEP-HFpEF und STEP-HFpEF DM
3. Heart failure, recurrent vascular events and death in patients with ischemic stroke—results of the MonDAFIS study
4. LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a simulation study
5. Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
6. Atherosklerotische Veränderungen als Teil eines natürlichen Alterungsprozesses?: Stellungnahme der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK) zum Leitfaden der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) 2023 „Medikamentöse Cholesterinsenkung zur Vorbeugung kardiovaskulärer Ereignisse“
7. Physical exercise as a treatment for persisting symptoms post-COVID infection: review of ongoing studies and prospective randomized controlled training study
8. Quality of life in patients with statin intolerance: a multicentre prospective registry study
9. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
10. Kardiovaskuläre Pharmakotherapie im Alter
11. PCSK9-directed therapies: an update
12. Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations
13. Red blood cell distribution width (RDW) is associated with unfavorable functional outcome after transfemoral transcatheter aortic valve implantation
14. Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source
15. Extent of routine diagnostic cardiac work-up at certified German stroke units participating in the prospective MonDAFIS study
16. Herz und Gehirn
17. Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
18. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
19. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
20. Replik zum Leserbrief bezüglich der Stellungnahme von Rauch et al. (2023) zum Leitfaden der Arzneimittelkommission der Deutschen Ärzteschaft (AkdÄ): „Medikamentöse Cholesterinsenkung zur Vorbeugung kardiovaskulärer Ereignisse“
21. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy
22. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
23. Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 3): Körperliches Training und Endothelfunktion
24. Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany
25. C-kitpos cells in the human left atrial appendage
26. Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design
27. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
28. The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment
29. Abstract 16852: Pathological ECG Findings in 24-h-Holter-ECGs in Patients With Ischemic Stroke
30. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
31. Fettstoffwechselstörungen: Hypercholesterinämie
32. Moderne Lipidsenker – ein Mittel gegen das Problem der Unterversorgung?
33. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
34. Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials
35. Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10
36. Kardiale Komorbidität – Möglichkeiten und Grenzen der perioperativen Konditionierung
37. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses
38. The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project
39. Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 2): Therapie von Komorbiditäten
40. Special aspects of cholesterol metabolism in women
41. Use of combination therapy is associated with improved LDL-cholesterol management: 1-year follow-up results from the European observational SANTORINI study
42. Detection of direct oral anticoagulants with the diluted Russel's viper venom time
43. DECLINING RATES OF FIXED-DOSE COMBINATION PILLS FOR HYPERTENSION IN GERMANY FROM 2016 TO 2023
44. Statinintoleranz und statinassoziierte Muskelschmerzen
45. Lipoproteinapherese: Übersicht und Fallbericht zur weltweit längsten HELP-Behandlung
46. PCSK9-Hemmung – ein Update
47. Travelling with heart failure: risk assessment and practical recommendations
48. Attenuation of the Heartbeat-Evoked Potential in Patients With Atrial Fibrillation
49. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials
50. Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz: Teil 1 – Arzneimitteltherapie
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.